On this episode of The Beat, Feyi Olopade Ayodele joins host Dr. Jessica Shepherd to explain how she built CancerIQ to solve for the disparity in access to genetic testing by making it part of everyone’s primary care visit. Feyi describes how CancerIQ helps patients initiate conversations around cancer prevention with their providers and gives providers the right precision prevention program for each patient. Listen in for Feyi’s insight on the emotional journey associated with a cancer diagnosis and learn how CancerIQ is helping African American and rural patient populations prevent cancer or detect it in its earliest stages.
For most cancers, Black Americans have the highest death rate and shortest survival of any patient population.
And access to genetic testing is key to eliminating this disparity.
Feyi Olopade Ayodele is Cofounder and CEO of CancerIQ, a company on a bold mission to end cancer as we know it by giving providers and health systems access to the latest innovations in early cancer detection and prevention.
Under Feyi’s leadership, CancerIQ has grown its provider network to over 200 locations across the US and established a robust ecosystem of leading diagnostic and genomic testing vendors.
On this episode of The Beat, Feyi joins host Dr. Jessica Shepherd to explain how she built CancerIQ to solve for the disparity in access to genetic testing by making it part of everyone’s primary care visit.
Feyi describes how CancerIQ helps patients initiate conversations around cancer prevention with their providers and gives providers the right precision prevention program for each patient.
Listen in for Feyi’s insight on the emotional journey associated with a cancer diagnosis and learn how CancerIQ is helping African American and rural patient populations prevent cancer or detect it in its earliest stages.
Topics Covered
Connect with Feyi Olopade Ayodele
Connect with Dr. Jessica Shepherd
Resources